Stewart Fabb

Stewart Fabb

Monash University

H-index: 14

Oceania-Australia

About Stewart Fabb

Stewart Fabb, With an exceptional h-index of 14 and a recent h-index of 7 (since 2020), a distinguished researcher at Monash University, specializes in the field of Molecular Biology, Cell Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting

Interim Results from a Phase I Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and mRNA Vaccines as a 4 th Dose Booster

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose …

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Dysregulated expression of Hoxa1 isoforms in hematopoietic stem and progenitor cells causes myelodysplastic syndromes

Multipathway In vitro pharmacological characterization of specialized proresolving G protein-coupled receptors

Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms

Adenovirus terminal protein contains a bipartite nuclear localisation signal essential for its import into the nucleus

Stewart Fabb Information

University

Position

___

Citations(all)

1485

Citations(since 2020)

327

Cited By

1301

hIndex(all)

14

hIndex(since 2020)

7

i10Index(all)

15

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Stewart Fabb Skills & Research Interests

Molecular Biology

Cell Biology

Top articles of Stewart Fabb

mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting

bioRxiv

2023

Interim Results from a Phase I Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and mRNA Vaccines as a 4 th Dose Booster

2023

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose …

EBioMedicine

2023/12/1

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Science Translational Medicine

2023/4/26

Dysregulated expression of Hoxa1 isoforms in hematopoietic stem and progenitor cells causes myelodysplastic syndromes

bioRxiv

2023/4/24

Chacko Joseph
Chacko Joseph

H-Index: 5

Stewart Fabb
Stewart Fabb

H-Index: 8

Multipathway In vitro pharmacological characterization of specialized proresolving G protein-coupled receptors

Molecular Pharmacology

2022/4/1

Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms

BMJ Open Diabetes Research and Care

2021/11/1

Adenovirus terminal protein contains a bipartite nuclear localisation signal essential for its import into the nucleus

International Journal of Molecular Sciences

2021/3/24

See List of Professors in Stewart Fabb University(Monash University)